RBC Europe’s Apollo Endosurgery, Inc. APEN Stock Holding History

RBC Europe’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1	Closed	-$9	–	1230
2021 Q3	$9	Hold	1	–	–	﹤0.01%	1233
2021 Q2	$8	Hold	1	–	–	﹤0.01%	1227
2021 Q1	$6	Hold	1	–	–	﹤0.01%	1178
2020 Q4	$3	Hold	1	–	–	﹤0.01%	1154
2020 Q3	$2	Hold	1	–	–	﹤0.01%	1101
2020 Q2	$2	Hold	1	–	–	﹤0.01%	1067
2020 Q1	$2	Hold	1	–	–	﹤0.01%	1045
2019 Q4	$3	Hold	1	–	–	﹤0.01%	1051
2019 Q3	$3	Hold	1	–	–	﹤0.01%	1054
2019 Q2	$3	Hold	1	–	–	﹤0.01%	1070
2019 Q1	$4	Hold	1	–	–	﹤0.01%	1083
2018 Q4	$3	Hold	1	–	–	﹤0.01%	1095
2018 Q3	$7	Hold	1	–	–	﹤0.01%	1131
2018 Q2	$7	Hold	1	–	–	﹤0.01%	1143
2018 Q1	$6	Hold	1	–	–	﹤0.01%	1124
2017 Q4	$6	Hold	1	–	–	﹤0.01%	1135
2017 Q3	$5	Buy	+1	New	+$5	﹤0.01%	1135

Other funds holding APEN

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

PGM

Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

RBC Europe's APEN Position: Q4 2021 in Review

RBC Europe sold out of Apollo Endosurgery, Inc. (APEN) in Q4 2021, closing a stake of 1 share — an estimated $9 sold.

RBC Europe first reported a position in APEN in Q3 2017 and held it in 17 quarters. The position peaked at $9 in Q3 2021. 72 funds tracked by Wall St. Rank hold APEN as of Q4 2021.

RBC Europe reported no remaining Apollo Endosurgery, Inc. position as of Q4 2021 after selling out during the quarter.
RBC Europe sold 1 Apollo Endosurgery, Inc. share in Q4 2021, an estimated $9.
RBC Europe first reported a position in Apollo Endosurgery, Inc. in Q3 2017 and held it in 17 quarters.
RBC Europe's Apollo Endosurgery, Inc. position peaked at $9 in Q3 2021.
72 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.